Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

26.53 +0.08 (+0.30%)
Official Closing Price Updated: 7:00 PM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
History Suggests These 3 Stocks Are Due for a Major Rebound ↗
Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Novavax (NVAX) Q1 2026 Earnings Transcript ↗
Novavax (NVAX) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill... 
Via StockStory
Pfizer Inc. (NYSE:PFE) Tops Q1 2026 Estimates Amid Strong Non-COVID Growth ↗
Via Chartmill
News headline image
PFE Q1 Deep Dive: Oncology, Obesity Pipeline, and Legal Milestones Shape Outlook
Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ... 
Via StockStory
Topics Intellectual Property
News headline image
Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime ↗
Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy. 
Via The Motley Fool
News headline image
Pfizer (PFE) Q1 2026 Earnings Transcript ↗
Pfizer (PFE) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View ↗
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance. 
Via Benzinga
Topics Intellectual Property
News headline image
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings ↗
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower. 
Via Benzinga
Topics Earnings Stocks
News headline image
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics ↗
Pfizer delivered better-than-expected sales and profit. 
Via Investor's Business Daily
News headline image
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th... 
Via StockStory
News headline image
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
From Pfizer Inc.
Via Business Wire
News headline image
Poets&Quants™ Names Best & Brightest MBAs of 2026
May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement 
Via 24-7 Press Release
News headline image
Pfizer, Pinterest And 3 Stocks To Watch Heading Into Tuesday ↗
US stock futures up, key stocks to watch today: Pfizer, Pinterest, PayPal, ON Semiconductor, AMD. Check out Benzinga Pro's premarket coverage. 
Via Benzinga
News headline image
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy ↗
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer. 
Via Benzinga
News headline image
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect ↗
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure. 
Via Investor's Business Daily
News headline image
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings ↗
Pfizer to release Q3 earnings on May 5, with analysts expecting 72 cents/share and a revenue of $13.8 billion. Annual dividend yield at 6.53%. 
Via Benzinga
News headline image
Eli Lilly Just Announced Fantastic News for Shareholders ↗
Lilly's weight loss drugs have been delivering blockbuster revenue. 
Via The Motley Fool
Topics Earnings
News headline image
Pfizer Earnings: What To Look For From PFE
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know. Pfizer beat analys... 
Via StockStory
News headline image
Pfizer Stock: Still Priced Like It's Dead Money ↗
Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%. 
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Oversold Stock Ready to Bounce Back and 2 We Find Risky
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co... 
Via StockStory
Topics Artificial Intelligence
News headline image
Pfizer Just Scored a Win That Wall Street Can't Ignore ↗
The pharmaceutical giant just extended the lifespan of one of its top drugs. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗
This particular player has seen its yield rise in recent years. 
Via The Motley Fool
News headline image
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study ↗
Pfizer reports Phase 3 data showing ELREXFIO improved progression-free survival versus standard therapy in multiple myeloma study. 
Via Benzinga
News headline image
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?
Although Bristol-Myers Squibb has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. 
Via Barchart.com
Topics ETFs
News headline image
Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
From Pfizer Inc.
Via Business Wire
News headline image
2 High-Yielding Dividend Stocks to Buy for Passive Income in April ↗
It's still time to pick up their shares on the dip. 
Via The Motley Fool
Topics Economy Intellectual Property
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
Should You Buy, Sell, or Hold Pfizer at $27? ↗
The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question mark. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.